Oncoinfluencers to Follow on Social Media: Dr. Katy Rezvani

We are excited to spotlight Dr. Katy Rezvani, a prominent figure in the oncology community, as our next oncoinfluencer.

Dr. Rezvani is highly active on both X and LinkedIn, where she shares valuable updates on cancer research, particularly focusing on advancements in immunotherapy. Her insights are particularly relevant for those interested in the latest developments in leukemia and lymphoma treatment.

Stay informed with Dr. Rezvani’s latest research and updates by following her on X/Twitter and LinkedIn.

About Katy Rezvani

Dr. Katy Rezvani is the Sally Cooper Murray Chair in Cancer Research at MD Anderson Cancer Center. Previously, she served as a Professor of Medicine and Chief of the Section of Cellular Therapy at MD Anderson. Her research centers on enhancing natural killer (NK) cell function against leukemia through genetic engineering techniques. Dr. Rezvani’s groundbreaking work has led to funded Phase I/II trials in leukemia and lymphoma immunotherapy.

While staying tuned for upcoming Oncoinfluencers, check out previous profiles on our website to learn more about influential voices in the oncology community.